This leads to peripheral and hepatic insulin resistance and compensatory intra-portal hyperinsulinemia, which results in increased hepatic GH sensitivity that aggravates the condition further (Table 1; Figures 1C, 3). Here, GH1 is linked to Hyperinsulinemia.